advanced NSCLC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
advanced NSCLC
Jun 16, 2024, 15:16 |
Insight
Cost of care discussions in medical records of patient with advanced NSCLC and melanoma - ACS Journal Cancer
Robin Yabroff, Scientific Vice President at the American Cancer Society, recently shared a post by…
Jun 8, 2024, 16:06 |
Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 1, 2024, 11:46 |
Blog
Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "Phase 2 study (OptiTROP-Lung01) had promising results in patients with advanced…
May 23, 2024, 07:39 |
Blog
Daniel Sterman: Congratulations Antonio Velez, on his superb presentation of our NCI-funded clinical trial
Daniel Sterman, Director of Division of Pulmonary, Critical Care, and Sleep Medicine at NYU Langone Health, made…
May 13, 2024, 14:29 |
Insight
Jarushka Naidoo: A step forward in implementing anti-PD(L)1 across growing not otherwise specified of indications?
Jarushka Naidoo shared on X: "Ph III IMscin001 trial of Subcutaneous (sc) vs IV Atezolizumab…
Apr 5, 2024, 18:10 |
Insight
Chul Kim: Check out our podcast on the importance of biomarker testing in the treatment of advanced NSCLC
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X: "Check out…
All:
6
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube